Rethy L. Petito L.C. Vu T.H.T. et al.

Trends in the prevalence of self-reported heart failure by race/ethnicity and age from 2001 to 2016.

JAMA Cardiology. 5: 1425-1429Hameed A. Karaalp I.S. Tummala P.P. et al.

The effect of valvular heart disease on maternal and fetal outcome of pregnancy.

J Am Coll Cardiol. 37: 893-899Seeburger J. Eifert S. Pfannmuller B. et al.

Gender differences in mitral valve surgery.

Thorac Cardiovasc Surg. 61: 42-46Nkomo V.T. Gardin J.M. Skelton T.N. et al.

Burden of valvular heart diseases: a population-based study.

Lancet (London, England). 368: 1005-1011Writing Committee M. Otto C.M. Nishimura R.A. et al.

2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

J Am Coll Cardiol. 77: e25-e197Asgar A.W. Mack M.J. Stone G.W.

Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations.

J Am Coll Cardiol. 65: 1231-1248Trichon B.H. Felker G.M. Shaw L.K. et al.

Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure.

Am J Cardiol. 91: 538-543Rossi A. Dini F.L. Faggiano P. et al.

Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy.

Heart (British Cardiac Society). 97: 1675-1680Hayek E. Gring C.N. Griffin B.P.

Mitral valve prolapse.

Lancet (London, England). 365: 507-518Hayward C. Monteiro R. Ferreira A. et al.

Racial differences in the aetiology of mitral valve disease.

Eur Heart J Qual Care Clin Outcomes. 7: e3-e4Breathett K. Leng I. Foraker R.E. et al.

Risk factor burden, heart failure, and survival in women of different ethnic groups: insights from the women's health initiative.

Circulation Heart Failure. 11: e004642Mantovani F. Clavel M.A. Michelena H.I. et al.

Comprehensive imaging in women with organic mitral regurgitation: implications for clinical outcome.

JACC Cardiovasc Imaging. 9: 388-396Avierinos J.F. Inamo J. Grigioni F. et al.

Sex differences in morphology and outcomes of mitral valve prolapse.

Ann Intern Med. 149: 787-795Vassileva C.M. McNeely C. Mishkel G. et al.

Gender differences in long-term survival of Medicare beneficiaries undergoing mitral valve operations.

Ann Thorac Surg. 96: 1367-1373

Women and coronary heart disease: a century after Herrick: understudied, underdiagnosed, and undertreated.

Circulation. 126: 604-611Daugherty S.L. Blair I.V. Havranek E.P. et al.

Implicit gender bias and the use of cardiovascular tests among cardiologists.

J Am Heart Assoc. 6https://doi.org/10.1161/JAHA.117.006872Breathett K. Yee E. Pool N. et al.

Association of gender and race with allocation of advanced heart failure therapies.

JAMA Netw Open. 3: e2011044Ilonze O. Free K. Breathett K.

Unequitable heart failure therapy for black, hispanic and american-indian patients.

Card Fail Rev. 8: e25Nayak A. Hicks A.J. Morris A.A.

Understanding the complexity of heart failure risk and treatment in black patients.

Circulation Heart Failure. 13: e007264Mathews L. Ding N. Sang Y. et al.

Racial differences in trends and prognosis of guideline-directed medical therapy for heart failure with reduced ejection fraction: the atherosclerosis risk in communities (ARIC) surveillance study.

J Racial Ethn Health Disparities. https://doi.org/10.1007/s40615-021-01202-5Heidenreich P.A. Bozkurt B. Aguilar D. et al.

2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation. 145: e895-e1032Spartera M. Galderisi M. Mele D. et al.

Role of cardiac dyssynchrony and resynchronization therapy in functional mitral regurgitation.

European Heart Journal Cardiovascular Imaging. 17: 471-480Thomas K.L. Al-Khatib S.M. Kelsey 2nd, R.C. et al.

Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of <or=35.

Am J Cardiol. 100: 924-929Farmer S.A. Kirkpatrick J.N. Heidenreich P.A. et al.

Ethnic and racial disparities in cardiac resynchronization therapy.

Heart Rhythm. 6: 325-331Sridhar A.R. Yarlagadda V. Parasa S. et al.

Cardiac resynchronization therapy: us trends and disparities in utilization and outcomes.

Circ Arrhythm Electrophysiol. 9: e003108Mwansa H. Barry I. Knapp S.M. et al.

Association between the affordable care act medicaid expansion and receipt of cardiac resynchronization therapy by race and ethnicity.

J Am Heart Assoc. 11: e026766Obadia J.F. Messika-Zeitoun D. Leurent G. et al.

Percutaneous repair or medical treatment for secondary mitral regurgitation.

N Engl J Med. 379: 2297-2306Stone G.W. Lindenfeld J. Abraham W.T. et al.

Transcatheter mitral-valve repair in patients with heart failure.

N Engl J Med. 379: 2307-2318Elbadawi A. Mahmoud K. Elgendy I.Y. et al.

Racial disparities in the utilization and outcomes of transcatheter mitral valve repair: insights from a national database.

Cardiovasc Revascularization Med. 21: 1425-1430Elbadawi A. Elzeneini M. Thakker R. et al.

Sex differences in in-hospital outcomes of transcatheter mitral valve repair (from a national database).

Am J Cardiol. 125: 1391-1397Gillinov A.M. Blackstone E.H. Nowicki E.R. et al.

Valve repair versus valve replacement for degenerative mitral valve disease.

J Thorac Cardiovasc Surg. 135 (): 885-893DiGiorgi P.L. Baumann F.G. O'Leary A.M. et al.

Mitral valve disease presentation and surgical outcome in African-American patients compared with white patients.

Ann Thorac Surg. 85: 89-93Vassileva C.M. Markwell S. Boley T. et al.

Impact of race on mitral procedure selection and short-term outcomes of patients undergoing mitral valve surgery.

Heart Surg Forum. 14: E221-E226Pienta M.J. Theurer P.F. He C. et al.

Racial disparities in mitral valve surgery: a statewide analysis.

J Thorac Cardiovasc Surg. https://doi.org/10.1016/j.jtcvs.2021.11.096Beydoun H.A. Beydoun M.A. Liang H. et al.

Sex, race, and socioeconomic disparities in patients with aortic stenosis (from a nationwide inpatient sample).

Am J Cardiol. 118: 860-865Osnabrugge R.L. Mylotte D. Head S.J. et al.

Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study.

J Am Coll Cardiol. 62: 1002-1012Singh J.P. Evans J.C. Levy D. et al.

Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study).

Am J Cardiol. 83: 897-902Patel D.K. Green K.D. Fudim M. et al.

Racial differences in the prevalence of severe aortic stenosis.

J Am Heart Assoc. 3: e000879Wilson J.B. Jackson 2nd, L.R. Ugowe F.E. et al.

Racial and ethnic differences in treatment and outcomes of severe aortic stenosis: a review.

JACC Cardiovasc Interv. 13: 149-156Chandra S. Lang R.M. Nicolarsen J. et al.

Bicuspid aortic valve: inter-racial difference in frequency and aortic dimensions.

JACC Cardiovasc Imaging. 5: 981-989Stewart B.F. Siscovick D. Lind B.K. et al.

Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study.

J Am Coll Cardiol. 29: 630-634Cao J. Steffen B.T. Budoff M. et al.

Lipoprotein(a) levels are associated with subclinical calcific aortic valve disease in white and black individuals: the multi-ethnic study of atherosclerosis.

Arterioscler Thromb Vasc Biol. 36: 1003-1009Leon M.B. Smith C.R. Mack M.J. et al.

Transcatheter or surgical aortic-valve replacement in intermediate-risk patients.

N Engl J Med. 374: 1609-1620Mack M.J. Leon M.B. Thourani V.H. et al.

Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients.

N Engl J Med. 380: 1695-1705Mack M.J. Lindenfeld J. Abraham W.T. et al.

3-year outcomes of transcatheter mitral valve repair in patients with heart failure.

J Am Coll Cardiol. 77: 1029-1040Smith C.R. Leon M.B. Mack M.J. et al.

Transcatheter versus surgical aortic-valve replacement in high-risk patients.

N Engl J Med. 364: 2187-2198Sleder A. Tackett S. Cerasale M. et al.

Socioeconomic and racial disparities: a case-control study of patients receiving transcatheter aortic valve replacement for severe aortic stenosis.

J Racial Ethn Health Disparities. 4: 1189-1194Cook N.L. Ayanian J.Z. Orav E.J. et al.

Differences in specialist consultations for cardiovascular disease by race, ethnicity, gender, insurance status, and site of primary care.

Circulation. 119: 2463-2470Breathett K. Liu W.G. Allen L.A. et al.

African Americans are less likely to receive care by a cardiologist during an intensive care unit admission for heart failure.

JACC Heart Failure. 6: 413-420Cruz Rodriguez B. Acharya P. Salazar-Fields C. et al.

Comparison of frequency of referral to cardiothoracic surgery for aortic valve disease in Blacks, Hispanics, and whites.

Am J Cardiol. 120: 450-455Barreto-Filho J.A. Wang Y. Dodson J.A. et al.

Trends in aortic valve replacement for elderly patients in the United States, 1999-2011.

JAMA. 310: 2078-2085Czarny M.J. Hasan R.K. Post W.S. et al.

Inequities in aortic stenosis and aortic valve replacement between Black/African-American, white, and Hispanic residents of Maryland.

J Am Heart Assoc. 10: e017487Yankey Jr., G.S. Jackson 2nd, L.R. Marts C. et al.

African American-Caucasian American differences in aortic valve replacement in patients with severe aortic stenosis.

Am Heart J. 234: 111-121Taylor N.E. O'Brien S. Edwards F.H. et al.

Relationship between race and mortality and morbidity after valve replacement surgery.

Circulation. 111: 1305-1312Alkhouli M. Holmes Jr., D.R. Carroll J.D. et al.

Racial disparities in the utilization and outcomes of TAVR: TVT registry report.

JACC Cardiovasc Interv. 12: 936-948Alkhouli M. Alqahtani F. Holmes D.R. et al.

Racial disparities in the utilization and outcomes of structural heart disease interventions in the United States.

J Am Heart Assoc. 8: e012125Gillum R.F. Gillum B.S. Francis C.K.

Coronary revascularization and cardiac catheterization in the United States: trends in racial differences.

J Am Coll Cardiol. 29: 1557-1562Peterson E.D. Shaw L.K. DeLong E.R. et al.

Racial variation in the use of coronary-revascularization procedures. Are the differences real? Do they matter?.

N Engl J Med. 336: 480-486Laouri M. Kravitz R.L. French W.J. et al.

Underuse of coronary revascularization procedures: application of a clinical method.

J Am Coll Cardiol. 29: 891-897Prihadi E.A. van der Bijl P. Gursoy E. et al.

Development of significant tricuspid regurgitation over time and prognostic implications: new insights into natural history.

Eur Heart J. 39: 3574-3581Nath J. Foster E. Heidenreich P.A.

Impact of tricuspid regurgitation on long-term survival.

J Am Coll Cardiol. 43: 405-409Topilsky Y. Maltais S. Medina Inojosa J. et al.

Burden of tricuspid regurgitation in patients diagnosed in the community setting.

JACC Cardiovasc Imaging. 12: 433-442

Tricuspid valve regurgitation: epidemiology and pathophysiology.

Minerva Cardioangiol. 66: 673-679Vieitez J.M. Monteagudo J.M. Mahia P. et al.

New insights of tricuspid regurgitation: a large-scale prospective cohort study.

Eur Heart J Cardiovasc Imaging. 22: 196-202Condello F. Gitto M. Stefanini G.G.

Etiology, epidemiology, pathophysiology and management of tricuspid regurgitation: an overview.

Rev Cardiovasc Med. 22: 1115-1142Aluru J.S. Barsouk A. Saginala K. et al.

Valvular heart disease epidemiology.

Med Sci. 10https://doi.org/10.3390/medsci10020032Rodés-Cabau J. Taramasso M. O'Gara P.T.

Diagnosis and treatment of tricuspid valve disease: current and future perspectives.

Lancet. 388: 2431-2442Alqahtani F. Berzingi C.O. Aljohani S. et al.

Contemporary trends in the use and outcomes of surgical treatment of tricuspid regurgitation.

J Am Heart Assoc. 6https://doi.org/10.1161/JAHA.117.007597Pfannmueller B. Eifert S. Seeburger J. et al.

Gender-dependent differences in patients undergoing tricuspid valve surgery.

Thorac Cardiovasc Surg. 61: 37-41Fam N.P. von Bardeleben R.S. Hensey M. et al.

Transfemoral transcatheter tricuspid valve replacement with the EVOQUE system: a multicenter, observational, first-in-human experience.

JACC Cardiovasc Interv. 14: 501-511Sedhom R. Megaly M. Saad M. et al.

Transcatheter edge-to-edge repair of the tricuspid valve: the US experience.

Catheter Cardiovasc Interv. 99: 1859-1866Lurz P. Stephan von Bardeleben R. Weber M. et al.

Transcatheter edge-to-edge repair for treatment of tricuspid regurgitation.

J Am Coll Cardiol. 77: 229-239Tsao C.W. Aday A.W. Almarzooq Z.I. et al.

Heart disease and stroke statistics-2022 update: a report from the American Heart Association.

Circulation. 145: e153-e639Choong C.Y. Abascal V.M. Weyman J. et al.

Prevalence of valvular regurgitation by Doppler echocardiography in patients with structurally normal hearts by two-dimensional echocardiography.

Am Heart J. 117: 636-642Heery E. Sheehan A.M. While A.E. et al.

Experiences and outcomes of transition from pediatric to adult health care services for young people with congenital heart disease: a systematic review.

Congenit Heart Dis. 10: 413-427Mazurenko O. Balio C.P. Agarwal R. et al.

The effects of Medicaid expansion under the ACA: a systematic review.

Health Aff. 37: 944-950Breathett K.K. Xu H. Sweitzer N.K. et al.

Is the affordable care act Medicaid expansion associated with receipt of heart failure guideline-directed medical therapy by race and ethnicity?.

Am Heart J. 244: 135-148Breathett K. Allen L.A. Helmkamp L. et al.

The affordable care act Medicaid expansion correlated with increased heart transplant listings in African Americans but not Hispanics or Caucasians.

JACC Heart Failure. 5: 136-147Warner J.J. Benjamin I.J. Churchwell K. et al.

Advancing healthcare reform: the American Heart Association's 2020 statement of principles for adequate, accessible, and affordable health care: a presidential advisory from the American Heart Association.

Circulation. 141: e601-e614D'Agostino R.S. Jacobs J.P. Badhwar V. et al.

The Society of Thoracic Surgeons adult cardiac surgery database: 2017 update on outcomes and quality.

Ann Thorac Surg. 103: 18-24Balady G.J. Ades P.A. Bittner V.A. et al.

Referral, enrollment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: a presidential advisory from the American Heart Association.

Circulation. 124: 2951-2960Sullivan L.T. Randolph T. Merrill P. et al.

Representation of black patients in randomized clinical trials of heart failure with reduced ejection fraction.

Am Heart J. 197: 43-52Reza N. Gruen J. Bozkurt B.

Representation of women in heart failure clinical trials: barriers to enrollment and strategies to close the gap.

Am Heart J. 13https://doi.org/10.1016/j.ahjo.2022.100093Scott P.E. Unger E.F. Jenkins M.R. et al.

Participation of women in clinical trials supporting FDA approval of cardiovascular drugs.

J Am Coll Cardiol. 71: 1960-1969Whitelaw S. Thabane L. Mamas M.A. et al.

Characteristics of heart failure trials associated with under-representation of women as lead authors.

J Am Coll Cardiol. 76: 1919-1930Clark L.T. Watkins L. Pina I.L. et al.

Increasing diversity in clinical trials: overcoming critical barriers.

Curr Probl Cardiol. 44: 148-172Ilonze O.J. Avorgbedor F. Diallo A. et al.

Addressing challenges faced by underrepresented biomedical investigators and efforts to address them: an NHLBI-PRIDE perspective.

J Natl Med Assoc. https://doi.org/10.1016/j.jnma.2022.09.007Oh S.S. Galanter J. Thakur N. et al.

Diversity in clinical and biomedical research: a promise yet to be fulfilled.

PLoS Med. 12: e1001918Morris A.A. Khazanie P. Drazner M.H. et al.

Guidance for timely and appropriate referral of patients with advanced heart failure: a scientific statement from the American Heart Association.

Circulation. 144: e238-e250Breathett K. Yee E. Pool N. et al.

Does race influence decision making for advanced heart failure therapies?.

J Am Heart Assoc. 8: e013592Thornton R.L. Powe N.R. Roter D. et al.

Patient-physician social concordance, medical visit communication and patients' perceptions of health care quality.

Patient Educ Couns. 85: e201-e208Jackson J.L. Kay C. Scholcoff C. et al.

Associations between gender and racial patient-physician concordance and visit outcomes among hypertensive patients in primary care.

J Gen Intern Med. 37: 1569-1571

Ethnic concordance in patient-physician communication: experimental evidence from Germany.

J Health Commun. 24: 1-8Perez-Stable E.J. El-Toukhy S.

Communicating with diverse patients: how patient and clinician factors affect disparities.

Patient Educ Couns. 101: 2186-2194Stout K.K. Daniels C.J. Aboulhosn J.A. et al.

2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

J Am Coll Cardiol. 73: e81-e192

Promotion OoDPaH. Social determinants of health. Healthy people 2030. U.S. Department of Health and Human Services. 2021. Available at: https://health.gov/healthypeople/objectives-and-data/social-determinants-health.

Churchwell K. Elkind M.S.V. Benjamin R.M. et al.

Call to action: structural racism as a fundamental driver of health disparities: a presidential advisory from the american heart association.

Circulation. 142: e454-e468

Racial and ethnic disparities in heart failure: current state and future directions.

Curr Opin Cardiol. 36: 320-328